Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia.
about
Kynurenines in CNS disease: regulation by inflammatory cytokinesToxoplasma gondii seropositivity and suicide rates in womenKynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controlsDownregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.Elevated cerebrospinal fluid kynurenic acid levels in patients with tick-borne encephalitisHas an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophreniaTargeted Deletion of Kynurenine 3-Monooxygenase in Mice: A NEW TOOL FOR STUDYING KYNURENINE PATHWAY METABOLISM IN PERIPHERY AND BRAINContinuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult ratsPre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood.Systemic L-Kynurenine sulfate administration disrupts object recognition memory, alters open field behavior and decreases c-Fos immunopositivity in C57Bl/6 mice.A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia.Potential role of the combination of galantamine and memantine to improve cognition in schizophreniaConcurrent quantification of tryptophan and its major metabolites.A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation.3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia.From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brainA systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of ratsImpaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia.Alternative kynurenic acid synthesis routes studied in the rat cerebellum.Humans as Superorganisms: How Microbes, Viruses, Imprinted Genes, and Other Selfish Entities Shape Our Behavior.Translating glutamate: from pathophysiology to treatment.Interferon-gamma - Inducible Inflammation: Contribution to Aging and Aging-Associated Psychiatric Disorders.Potato- an important source of nutritional kynurenic acidInfluence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophreniaSerum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case-control study.Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder.Latent toxoplasmosis and humanMetabolomic Profiling of Mice Serum during Toxoplasmosis Progression Using Liquid Chromatography-Mass Spectrometry.Exposure to kynurenic acid during adolescence produces memory deficits in adulthood.Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantineAcute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine.Kynurenic Acid in the digestive system-new facts, new challenges.The effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: Implications for schizophrenia.Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia.Effects of Kynurenine Pathway Inhibition on NAD Metabolism and Cell Viability in Human Primary Astrocytes and Neurons.Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.Effects of Resveratrol and Other Polyphenols on Sirt1: Relevance to Brain Function During Aging.
P2860
Q21129356-086C95C5-909C-4535-9DA9-F913844674E1Q24599367-7F0DBEBB-C610-4ACE-9B85-A3DD0515A27DQ24623659-D9521D44-22AB-491B-97E2-FB4244EDCAD1Q24631189-83D930C8-7818-4B61-A09A-993853231015Q28262656-46C2FD97-29FD-4AE2-9CF0-BB156AAEB819Q28275290-94B71E1F-A837-47DE-A048-5A46F5CFD265Q29306917-A543BCA5-8C48-47BE-8113-14432C68B4D6Q30408061-87EBA369-A848-4057-96C2-83D7E92A4704Q30544793-15FE1600-CF97-44AD-B694-3EABB6963B25Q30654478-A61FFC77-92A4-403E-8323-F68B2D6F3E29Q33624417-01AACF1A-256E-4EB5-A7CC-596B569B3EFFQ33905343-6149D38B-5E22-43D3-BD6F-3F66387B6D3FQ34118912-DC49F85B-2A39-4326-A617-D20ED3694403Q34405264-75B151B9-E4FC-4344-BD9D-2610B1A4D374Q34626655-4F0B99A0-3259-4262-B81C-C8428504E2CAQ34632695-14914D96-1437-4C56-B11F-9D8EFF0A47BAQ35003093-E9C1AA17-1518-4ECC-B65B-06F07BAC52B2Q35213516-31949336-69E3-41B1-826E-9C77A733971EQ35390305-DA71400B-1F77-4A68-BE8E-86EB27E5B0E5Q35618064-CC5B2ACB-EEE6-485C-9260-1EF3B1555DBCQ35692856-90B16680-0230-4265-A6A3-0ACCBAE8F87BQ35739457-F0F51AA8-6B14-4140-AE93-BCE4677A8837Q35806777-44BC76D1-C5C6-448D-A639-C25675D7CE94Q35831201-30E7E605-F986-4BBD-92AB-FA7E3AE002F1Q35892576-1FBAE64F-77CC-45AE-920F-97DFC2F091D2Q36256757-30C0325B-145C-48D6-B592-79E8F5E79F5BQ36310734-EB4F6D3F-F6D0-433F-BBE7-A2C3F61CB6EBQ36370599-619D9821-36D5-458A-AA8B-621289967B0CQ36500514-CBAEBFB8-A446-4D91-AA2B-7A6A724E5911Q36623248-8CC6049C-F3AD-44B2-B0C5-B9ED76A53D12Q36778677-CE656335-F07E-4D67-8C57-7348CCAD5EBEQ36883052-EFB5A4DA-A631-4CD3-94DF-33FB6CB65111Q37170524-59AED02D-6825-4C2F-A2C6-36B2CCB4461AQ37351984-37928270-D21A-427B-AA00-0591D8876F76Q37580309-B36B1E9E-C68F-4E53-A9FD-6A211BC3EFA6Q38281865-DA06D4DF-4912-4974-BF9A-8AD99E29B06FQ38728529-38EB2227-5C81-47AA-8715-9D1358519A69Q39130393-23756821-D80D-4E2C-B5BD-436E3A729E04Q39185463-031AD976-5B0E-47BC-9C9B-2B2162D79DA8Q39413673-5557ADBC-4E49-4F1B-86F9-DD22272A0E49
P2860
Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cortical kynurenine pathway me ...... enhancement in Schizophrenia.
@ast
Cortical kynurenine pathway me ...... enhancement in Schizophrenia.
@en
type
label
Cortical kynurenine pathway me ...... enhancement in Schizophrenia.
@ast
Cortical kynurenine pathway me ...... enhancement in Schizophrenia.
@en
prefLabel
Cortical kynurenine pathway me ...... enhancement in Schizophrenia.
@ast
Cortical kynurenine pathway me ...... enhancement in Schizophrenia.
@en
P2860
P356
P1476
Cortical kynurenine pathway me ...... enhancement in Schizophrenia.
@en
P2093
Ikwunga Wonodi
Robert Schwarcz
P2860
P304
P356
10.1093/SCHBUL/SBQ002
P407
P577
2010-02-10T00:00:00Z